<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04785209</url>
  </required_header>
  <id_info>
    <org_study_id>Prediction of No reflow</org_study_id>
    <nct_id>NCT04785209</nct_id>
  </id_info>
  <brief_title>Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.</brief_title>
  <official_title>Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing PPCI.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Predicting no reflow in ppci of STEMI patients using mean platelet volume together with STEMI&#xD;
      clinical risk scores&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participents with No reflow after PPCI and in hospital mortality</measure>
    <time_frame>Within 48 hours from admission</time_frame>
    <description>No reflow: suboptimal myocardial reperfusion through a part of coronary circulation without angiographic evidence of mechanical vessel obstruction.&#xD;
In hospital mortality</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">84</enrollment>
  <condition>No-Reflow Phenomenon</condition>
  <arm_group>
    <arm_group_label>No complication</arm_group_label>
    <description>Thrombolysis in myocardial infarction flow grade III flow after PPCI, mean platelet volume, lymphocyte ratio, detailed echo within 24 hrs of admission, clinical STEMI risk scores</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No reflow</arm_group_label>
    <description>No reflow phenomenon after pci on STEMI patients, mean platelet volume, lymphocyte ratio, detailed echo within 24 hrs of admission, clinical STEMI risk scores</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mean platelet volume, lymphocyte number, STEMI clinical risk scores</intervention_name>
    <description>Lab parameters</description>
    <arm_group_label>No complication</arm_group_label>
    <arm_group_label>No reflow</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All STEMI patients presenting within 24 hrs of onset of symptoms&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients presenting with acute STEMI, within 24 hours of symptoms, fulfilling criteria&#xD;
             for PPCI protocol in our facility&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients presenting more than 24 hours of symptoms onset&#xD;
&#xD;
          -  patients not eligible for PPCI program in our facility&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Hamdy Shams elddin, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew Salama, Resident</last_name>
    <phone>+201210999130</phone>
    <email>Andrew.rey@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shaimaa Khedr, Assistant lecturer</last_name>
    <phone>+201001346551</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assiut university hospital</name>
      <address>
        <city>Assiut</city>
        <zip>71515</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Salama</last_name>
      <phone>+201210999130</phone>
      <email>andrew.rey@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>September 23, 2020</study_first_submitted>
  <study_first_submitted_qc>March 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2021</study_first_posted>
  <last_update_submitted>March 2, 2021</last_update_submitted>
  <last_update_submitted_qc>March 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Andrew Reymon Sadik Salama</investigator_full_name>
    <investigator_title>Principle invistigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>No-Reflow Phenomenon</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

